Screening for atrial fibrillation

Скрининг на фибрилляцию предсердий
Zhenisgul Tlegenova 1, Gulmira Kudaiberdieva 2, Bekbolat Zholdin 1, Ayan Abdrakhmanov 3
More Detail
1 No 2 Department of Internal Medicine, Marat Ospanov West Kazakhstan State Medical University, Aktobe, Republic of Kazakhstan
2 Center of Postgraduate Education and Research, Bishkek, Kyrgyzstan
3 Interventional Arrhythmology Department, National Research Cardiac Surgery Center, Astana, Republic of Kazakhstan
J CLIN MED KAZ, Volume 1, Issue 47, pp. 18-24. https://doi.org/10.23950/1812-2892-JCMK-00542
OPEN ACCESS 4270 Views 3446 Downloads
Download Full Text (PDF)

ABSTRACT

Atrial fibrillation is the most common arrhythmia that physicians face in their clinical practice. Atrial fibrillation is associated with a higher risk of thromboembolic events, all-cause mortality, frequent hospitalizations, decreased quality of life. Early detection of atrial fibrillation is important for optimal management and improvement the prognosis of atrial fibrillation patients. Evidence on new methods of atrial fibrillation screening discussed in this review, allows considering them more accurate than simple pulse palpation.
Keywords: atrial fibrillation, stroke, screening, electrocardiogram

CITATION

Tlegenova Z, Kudaiberdieva G, Zholdin B, Abdrakhmanov A. Screening for atrial fibrillation. Journal of Clinical Medicine of Kazakhstan. 2018;1(47):18-24. https://doi.org/10.23950/1812-2892-JCMK-00542

REFERENCES

  • Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol. 2014; 6:213-220. doi:10.2147/CLEP.S47385.
  • Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et all. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014; 129(8):837-847. doi:10.1161/CIRCULATIONAHA.113.005119.
  • Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et all. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31(19):2369-2429. doi:10.1093/eurheartj/ehq278.
  • Murphy A, Banerjee A, Breithardt G, Camm AJ, Commerford P, Freedman B, et all.The World Heart Federation Roadmap for Nonvalvular Atrial Fibrillation. Glob Heart. 2017; 12(4):273-284. doi:10.1016/j.gheart.2017.01.015.
  • Potpara TS, Polovina MM, Marinkovic JM, Lip GY. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int J Cardiol. 2013; 168(5):4744-4749. doi:10.1016/j.ijcard.2013.07.234.
  • Friberg L, Engdahl J, Frykman V, Svennberg E, Levin LÅ, Rosenqvist M. Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). Europace. 2013; 15(1):135-140. doi:10.1093/europace/eus217.
  • Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007; 146(12):857-867. PubMed PMID: 17577005
  • Boriani G, Laroche C, Diemberger I, Fantecchi E, Popescu MI, Rasmussen LH, et all. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2015; 128(5):509-518.e2. doi:10.1016/j.amjmed.2014.11.026.
  • Martinez C, Katholing A, Freedman SB. Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost. 2014; 112(2):276-286. doi: 10.1160/TH4-04-0383.
  • Neubeck L, Orchard J, Lowres N, Freedman SB. To Screen or Not to Screen?Examining the Arguments Against Screening for Atrial Fibrillation. Heart LungCirc. 2017; 26(9):880-886. doi: 10.1016/j.hlc.2017.05.118.11.
  • Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? JR Coll Physicians Edinb. 2012; 42 Suppl18:5-22. doi:10.4997/JRCPE.2012.S02.Review.
  • Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998; 82(8A):2N-9N.PubMedPMID: 9809895.
  • Chamberlain AM, Agarwal SK, Folsom AR, Soliman EZ, Chambless LE, Crow R, et all. A clinical risk score for atrial fibrillation in a biracial prospective cohort (from the Atherosclerosis Risk in Communities [ARIC] study). Am J Cardiol. 2011; 107(1):85-91. doi:10.1016/j.amjcard.2010.08.049.
  • Saliba W, Gronich N, Barnett-Griness O, Rennert G. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study. Am J Med. 2016; 129(8):843-849. doi:10.1016/j.amjmed.2016.02.029.
  • Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for diagnosing atrial fibrillation using 12-lead ECG: A systematic review and meta-analysis. Int J Cardiol. 2015; 184:175-183. doi:1016/j.ijcard.2015.02.014.
  • Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et all. [2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS]. Kardiol Pol. 2016; 74(12):1359-1469. doi:10.5603/KP.2016.0172. Polish.
  • Willits I, Keltie K, Craig J, Sims A. Watch BP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: a NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2014; 12(3):255-265. doi: 10.1007/s40258-014-0096-7.
  • Doliwa PS, Rosenqvist M, Frykman V. Paroxysmal atrial fibrillation with silent episodes: intermittent versus continuous monitoring. Scand Cardiovasc J. 2012; 46(3):144-148. doi:10.3109/14017431.2012.661873.
  • Svennberg E, Stridh M, Engdahl J, Al-Khalili F, Friberg L, Frykman V, et all. Safe automatic one-lead electrocardiogram analysis in screening for atrial fibrillation. Europace. 2017; 19(9):1449-1453. doi:10.1093/europace/euw286.
  • Rosenberg MA, Samuel M, Thosani A, Zimetbaum PJ. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013; 36(3):328-333. doi:10.1111/pace.12053.
  • Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, et all. ESC Scientific Document Group. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Europace. 2017; 19 (10):1589-1623. doi:10.1093/europace/eux177.
  • Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J,et all. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost. 2014; 111(6):1167-1176. doi:10.1160/TH14-03-0231.
  • Kaasenbrood F, Hollander M, Rutten FH, Gerhards LJ, Hoes AW, Tieleman RG. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination. Europace. 2016; 18(10):1514-1520.
  • Smyth B, Marsden P, Corcoran R, Walsh R, Brennan C, McSharry K, Clarke J, Kelly PJ, Harbison J. Opportunistic screening for atrial fibrillation in a rural area. QJM. 2016; 109(8):539-543. doi:10.1093/qjmed/hcw011.
  • Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation. 2013; 127(8):930-937. doi:10.1161/CIRCULATIONAHA.112.126656.
  • Proietti M, Mairesse GH, Goethals P, Scavee C, Vijgen J, Blankoff I, et all Belgian Heart Rhythm Week Investigators. A population screening programme for atrial fibrillation: a report from the Belgian Heart Rhythm Week screening programme. Europace. 2016; 18(12):1779-1786. doi:10.1093/europace/euw069.
  • Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et all Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomized controlled trial. BMJ. 2007; 335(7616):383.
  • Moran PS, Teljeur C, Ryan M, Smith SM. Systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev. 2016; (6):CD009586. doi:10.1002/14651858.CD009586.pub3.
  • Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et all; Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014; 13(4):429-438. doi: 10.1016/S1474-4422(13)70310-7.
  • Suissa L, Lachaud S, Mahagne MH. Optimal timing and duration of continuous electrocardiographic monitoring for detecting atrial fibrillation in stroke patients. J Stroke Cerebrovasc Dis. 2013; 22(7): 991-995. doi:10.1016/j.jstrokecerebrovasdis.2012.01.015.
  • Wachter R, Weber-Krüger M, Seegers J, Edelmann F, Wohlfahrt J, Wasser K, et all Age-dependent yield of screening for undetected atrial fibrillation in stroke patients: the Find-AF study. J Neurol. 2013; 260(8):2042-2045. doi:10.1007/s00415-013-6935-x.
  • Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, et all; EMBRACE Investigators and Coordinators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014; 370(26):2467-2477. doi:10.1056/NEJMoa1311376.
  • Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et all; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014; 26;370(26):2478-2486. doi:10.1056/NEJMoa1313600.
  • Gorenek B, Bax J, Boriani G, Chen SA, Dagres N, Glotzer TV, et all; ESC Scientific Document Group. Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 2017; 19(9):1556-1578. doi:10.1093/ europace/eux163.
  • Mahajan R, Perera T, Elliott AD, Twomey DJ, Kumar S, Munwar DA, et all Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis. Eur Heart J. 2018; doi:10.1093/eurheartj/ehx731.
  • Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, et all; MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke:report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation. 2003; 107(12):1614-1619. Epub 2003 Mar 24. PubMed PMID:12668495.
  • Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et all; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012; 366(2):120-129. doi:10.1056/NEJMoa1105575.
  • Gonzalez M, Keating RJ, Markowitz SM, Liu CF, Thomas G, Ip JE, et all Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers. Heart Rhythm. 2014; 11(12):2214-2221. doi: 10.1016/j. hrthm.2014.08.019.
  • Lorenzoni G, Folino F, Soriani N, Iliceto S, Gregori D. Cost-effectiveness of early detection of atrial fibrillation via remote control of implanted devices. J Eval Clin Pract. 2014; 20(5):570-577. doi: 10.1111/jep.12132.
  • Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC, et all Outcome parameters for trials in atrial fibrillation: executive summary: Recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork (AFNET) and the European Heart Rhythm Association (EHRA). EurHeart J. 2007; 28(22):2803-2817.
  • Davis RC, Hobbs FD, Kenkre JE, Roalfe AK, Iles R, Lip GY, et all Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. Europace. 2012; 14(11):1553-1559. doi:10.1093/europace/eus087.
  • Lowres N, Neubeck L, Redfern J, Freedman SB. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost. 2013; 110(2):213- 222. doi: 10.1160/TH13-02-0165.
  • Grond M, Jauss M, Hamann G, Stark E, Veltkamp R, Nabavi D, et all. Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Stroke. 2013; 44(12):3357-3364. doi:10.1161/STROKEAHA.113.001884.
  • Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, et all Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012; 43(10):2689- 2694. Epub 2012 Aug 7. PubMed PMID: 22871678.
  • Israel CW, Grönefeld G, Ehrlich JR, Li YG, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. J Am Coll Cardiol. 2004; 43(1):47-52
  • Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study. Circulation. 2015; 131(25):2176-2184. doi:10.1161/CIRCULATIONAHA.114.014343.